KBI Biopharma
Oct 11, 2018
COMMERCIAL AND OTHERS
Cytosen Therapeutics and KBI Biopharma pair up to manufacture NK cells and Nanoparticles CytoSen Therapeutics and KBI Biopharma paired up to manufacture therapeutic Natural Killer Cell by using a closed system manufacturing process. According to the initial collaboration, KBI will be subjected to manufactur...
Read More...
-Agonist.png "Toll-like Receptors Agonist")
